author-photo

Jane Coates Ulrichsen

MedImmune

9

Papers

317

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (34)
Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery

2017 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (196)
Abstract 4186: Syngenomic fingerprint: the biomic characterization of the mouse syngeneic tumor models

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (55)
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (30)
Abstract 289: The combination of CD40 agonism and PD-L1 blockade enhances anti-tumor immunity in a mouse syngeneic orthotopic pancreatic tumor model

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 1651: Profiling immune cells within the tumor microenvironment for optimal model selection for pre-clinical investigations

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1663: CD40 agonists drive the anti-tumor functions of macrophages and induce systemic immune activation survival the Pan02 orthotopic pancreatic model

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4613: Identification of tumor necrosis factor receptor II as a regulatory T cell target for cancer immunotherapy using designed ankyrin repeat protein phenotypic selections

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)